Sarah Bonaffini in Ocean City, New Jersey

Home New Jersey Ocean City

Sarah Bonaffini has Ophthalmology as her primary medical specialty. Their primary office is: 2401 Bay Ave in Ocean City, New Jersey. There is an additional office location, for a total of two, for Sarah Bonaffini that can be viewed further down.

They're a part of the: Horizon Eye Care Pa medical group which has around 12 members. You can call their office at 609-399-6102 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Lake Erie College Of Osteopathic Medicine, Bradenton and graduated in 2017 (around 7 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Sarah Genevieve Bonaffini Office Phone and Directions

Sarah Bonaffini
Horizon Eye Care Pa
2401 Bay Ave
Ocean City, New Jersey 08226
609-399-6102

Patient Ratings
Please rate your experience with Sarah Bonaffini below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 609-399-6102

Enter a starting address:

Healthcare Info for Sarah Bonaffini

Medical School: Lake Erie College Of Osteopathic Medicine, Bradenton
Graduation Year: 2017
The Primary Medical Specialty for Sarah Bonaffini is listed as: Ophthalmology
Approximate Years of Experience: 7
PAC (PECOS ID)#: 4587067830
NPI #: 1457892119
NPI Created On: 03/14/2017
NPI Last Updated Listed as: 08/03/2022
Primary Taxonomy Code: 207W00000X
License Number:
25MB11516700
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851224915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Ophthalmology

Name of Drug #1: VYZULTA

Open Associated Drug #1: 24208-504-05